Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia.

Source:http://linkedlifedata.com/resource/pubmed/id/19965685

Blood 2010 Jan 21 115 3 559-69

Download in:

View as

General Info

PMID
19965685